.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chubb
Baxter
McKinsey
US Army
Fish and Richardson
Covington
QuintilesIMS
Citi
Chinese Patent Office

Generated: February 25, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9826882.4

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-001Aug 29, 2012RXYesNo➤ Sign Up➤ Sign UpY
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-002Aug 29, 2012RXYesNo➤ Sign Up➤ Sign UpY
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-003Aug 29, 2012RXYesYes➤ Sign Up➤ Sign UpY
NovartisAFINITOReverolimusTABLET;ORAL022334-003Jul 9, 2010RXYesNo➤ Sign Up➤ Sign UpY
NovartisAFINITOReverolimusTABLET;ORAL022334-001Mar 30, 2009RXYesNo➤ Sign Up➤ Sign UpY
NovartisAFINITOReverolimusTABLET;ORAL022334-004Mar 30, 2012RXYesNo➤ Sign Up➤ Sign UpY
NovartisAFINITOReverolimusTABLET;ORAL022334-002Mar 30, 2009RXYesYes➤ Sign Up➤ Sign UpY
NovartisAFINITOReverolimusTABLET;ORAL022334-003Jul 9, 2010RXYesNo➤ Sign Up➤ Sign UpY
NovartisAFINITOReverolimusTABLET;ORAL022334-001Mar 30, 2009RXYesNo➤ Sign Up➤ Sign UpY
NovartisAFINITOReverolimusTABLET;ORAL022334-004Mar 30, 2012RXYesNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist